Efficacy of mummy on healing of pressure ulcers
A randomized controlled clinical trial on hospitalized patients in intensive care unit
Keywords:
Pressure ulcer, Mummy, Intensive care unitAbstract
Abstract Background: Mummy is a mineral substance which according to Persian medicine texts, may be useful in treatment of chronic ulcers. Objective: The present study was performed with the aim of determining the effect of mummy on healing of pressure in male patients who had been hospitalized due to cerebrospinal injury in the Intensive Care Unit. Methods: This randomized, placebo-controlled clinical trial was performed on 75 patients who had pressure ulcer at Shahid Bahonar Hospital in Kerman, Iran, from September 2016 to March 2017. The control group received normal saline and routine wound dressing, while the intervention group received mummy water solution 20% in addition to normal saline and routine wound dressing on a daily basis. Data was recorded based on the PUSH method. In both groups, ulcers were evaluated on days 0, 7, 14, 21 and 28 for the variables of ulcer surface area, the amount of exudate and type of tissue. Data analysis was done through SPSS 21 and using t-test, Repeated Measure Analysis, Cox Regression and Chi-square. Results: Both groups showed reduction in the average ulcer surface area (3.26 to 0.53 in the intervention group and 5.1 to 3.46 in the control group), the average exudate amount (1.26 to 0.26 in the intervention group and 1.83 to 1.06 in the control group) and the average tissue score (1.36 to 0.23 in the intervention group and 2.13 to 1.26 in the control group). Over the entire study period, the intervention group showed more acceptable signs of healing compared to the control group (p<0.05). Conclusion: The healing process was more prominent in the intervention group than the control group. Clinical trial registration: The trial was registered at the Iranian Registry of Clinical Trials with registered NO. (IRCT2014042917494N1) (29/04/2014). Funding: No financial support for the research.References
Berton B, Berton M. The management and prevention of pressure sore. londan berandfaber. 2001; 4: 16-21.
Fleck CA. Pressure ulcers risks causes, and prevention Extended Care Product News. 2005; 105: 32-40.
Uzun O, Aylaz R, Karadağ E. prospective study: reducing pressure ulcers in intensive care units at a
Turkish medical center. J Wound Ostomy Continence Nurs. 2009; 36(4): 404-11. doi:
1097/WON.0b013e3181aaf524. PMID: 19609161.
Filius A, Damen TH, Schuijer-Maaskant KP, Polinder S, Hovius SE, Walbeehm ET. Cost analysis of
surgically treated pressure sores stage III and IV. J Plast Reconstr Aesthet Surg. 2013; 66(11): 1580-6. doi:
1016/j.bjps.2013.05.014. PMID: 23759717.
Hunter SM, Cathcart-Silberberg T, Langemo DK, Olson B, Hanson D, Burd C, et al. Pressure ulcer
prevalence and incidence in rehabilitation in hospital. Rehabil Nurs. 1999; 17(5): 239-42. doi:
1002/j.2048-7940.1992.tb01557.x. PMID: 1448603.
Fatemi MJ. pressure ulcer. Tehran: Nashre Chapar; 2015.
Aghili M. Mkhzan ol advieh. Tehran: Tehran University of Medical Sciences; 2010.
Ghosal S. Shilajit in Perspective. New Delhi India: Narosa Publishing House; 2006.
Tajadini H, Moghaderi M, Mehrabani M, Ahmadinegad M. Mummy (Shilajit) In Traditional Persian
Medicine. International Journal of Biotechnology and Research. 2017; 8(2): 1297-301.
Goel RK, Banerjee RS, Acharya SB. Antiulcerogenic and antiiflammatory studies with shillajit. J
Ethnopharmacol. 1990; 29(1): 95-103. doi: 10.1016/0378-8741(90)90102-Y. PMID: 2345464.
Acharya SB, Frotan MH, Goel RK, Tripathi SK, Das PK. Pharmacological actions of Shilajit. Ind J Expt
Biol. 1988; 26(10): 775-7. PMID: 3248832.
Rezvanipour M, Pourzadehhosseini F, Malekpour R, Zarabi A. The Effect of Mummy on Some Indices of
Wound Healing in Mice. Journal of Kerman University of Medical Sciences. 2007; 14(4): 267-77.
Wilson E, Rajamanickam GV, Dubey GP, Klose P, Musial F, Saha FJ, et al. Review on shilajit used in
traditional Indian medicine. J Ethnopharmacol. 2011; 136(1): 1-9. doi: 10.1016/j.jep.2011.04.033. PMID:
Gardner SE, Frantz RA, Berguist S, Shin CD. A prospective study of the pressre ulcer scale for healing
([PUSH). J Gerontol A Biol Sci Med Sci. 2005; 60(1): 93-7. doi: 10.1093/gerona/60.1.93. PMID:
Tavakoli MA, Khaksari MH, Asar SK. Comparison of using topical mummy and phenytoin creams on skin
wound healing of rats. J babol University Med Sci. 2003; 5(2): 7-13.
Rezvani-Pour M, Khatibi H. Effects of Mummy on the fracture healing in rabbit dispatching. J Kerman
Univ Med Sci. 2007; 14(4): 267-77.
Azimian J, Pourkhalegh E, Ansari M. Assessing the topical high pressure oxygen therapy in healing of
bedsore. J Qazvin Univ Med Sci. 2010; 13(4): 63-8.
Edsberg LE, Brogan MS, Jaynes CD, Fries K. Topical hyperbaric oxygen and electrical stimulation:
Exploring potential synergy. Ostomy Wound Manage. 2002; 48(11): 42-50. PMID: 12426451.
Azeri A, Khyrandysh R, Srdarmhny V, Salary A. The effect of mummy on healing skin lesions in rabbits.
Journal of Sabzevar University Of Medicine. 2011; 18(3): 158-65.
Dehghan M, Sharifi Faradonbeh A. The effect of mummy on the healing of bone fractures. African Journal
of Pharmacy and Pharmacology. 2012; 6(5): 305-30. doi: 10.5897/AJPP11.353.
Fatemi E. Comparing effectiveness of dressing, ultrasound and laser in healing of bedsore. Journal of Kosar
Medicine. 1999; 3(4): 33-6.
Ghosal S, Lata S, Kumar Y, Gaur B, Misra N, Soumya L. Interaction of shilajit with biogenic free radicals.
Indian Journal of Chemistry B. 1995; 34: 596-602.
Wang C, Wang Z, Peng A, Hou J, Xin W. Interaction between fulvic acids of different origins and active
oxygen radicals. Sci China C Life Sci. 1996; 39(3): 267-75. PMID: 8760456.
Acharya SB, Frotan MH, Goel RK, Tripathi SK, Das PK. Pharmacological actions of shilajit. Indian J Exp
Biol. 1988; 26(10): 775-7. PMID: 3248832.
Bhattacharya SK, Sen AP, Ghosal Sh. Effects of shilajit on biogenic free radicals. Phytotherapy Research.
; 9(1): 56-9. doi: 10.1002/ptr.2650090113.
Published
Issue
Section
License
Copyright (c) 2020 knowledge kingdom publishing
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.